Louis S. Goodman

Last updated • 2 min readFrom Wikipedia, The Free Encyclopedia
Louis Goodman
Louise Goodman Yale.jpg
Born(1906-08-27)August 27, 1906
DiedNovember 19, 2000(2000-11-19) (aged 94)
Alma mater Reed College (B.S.)
University of Oregon (M.D.)
Known forExperimental chemotherapy; The Pharmacological Basis of Therapeutics
SpouseHelen Ricen (1906–1996)
ChildrenCarolyn, Debora
AwardsNational Academy of Sciences (1965)
Scientific career
FieldsPharmacology
Institutions Yale School of Medicine
University of Vermont
University of Utah

Louis Sanford Goodman (August 27, 1906 – November 19, 2000) was an American pharmacologist. He is best known for his collaborations with Alfred Gilman, Sr., with whom he authored the popular textbook The Pharmacological Basis of Therapeutics in 1941 and pioneered the first chemotherapy trials using nitrogen mustard.

Contents

Life and career

Goodman was born in Portland, Oregon in 1906 and received his B.A. from Reed College in 1928 and an M.D. from the University of Oregon Medical School in 1932. [1] After interning at Johns Hopkins Hospital, he joined the Yale School of Medicine faculty, where he met Alfred Gilman. They began teaching pharmacology courses together and began to develop a textbook, which was published as The Pharmacological Basis of Therapeutics in 1941. [2]

While at Yale, Goodman and Gilman were assigned a government contract in nitrogen mustard research in 1942. [3] With knowledge that the compound depleted white blood cells, the pharmacologists experimented with intravenous injections on a terminally ill lymphosarcoma patient in Gustaf Lindskog's care. Though the tumor regenerated and killed the patient, the drug's success in briefly eliminating the tumor is considered a historic accomplishment in chemotherapy treatment, and the compound is still used as a chemotherapeutic agent. [3]

Goodman was appointed an assistant professor at the University of Vermont in 1937, and became its chair of pharmacology and physiology in 1943. [1] [4] Then, in 1944, he moved to Salt Lake City to found a department of pharmacology at the University of Utah College of Medicine. [5] There, Goodman demonstrated that the paralysis induced by curare was temporary, which he did by injecting a colleague with the relaxant. [1]

Goodman retired in 1971 and remained in Salt Lake City for the remainder of his life, continuing to teach at the College of Medicine. [5] He died on November 19, 2000, at the age of 94. [1]

Personal life

Goodman married Helen Ricen in 1934, and they had two daughters, Carolyn and Debora. He is survived by his grandchildren, Jonathan, Rebecca, Miriam and Jacob and great-grandson Leo Goodman Liggins.[ citation needed ]

Awards and honors

Goodman was elected to the National Academy of Sciences in 1965. [4]

Related Research Articles

<span class="mw-page-title-main">Yale School of Medicine</span> Private medical school in New Haven Connecticut, US

The Yale School of Medicine is the medical school at Yale University, a private research university in New Haven, Connecticut. It was founded in 1810 as the Medical Institution of Yale College and formally opened in 1813.

<span class="mw-page-title-main">Alfred G. Gilman</span> American pharmacologist (1941–2015)

Alfred Goodman Gilman was an American pharmacologist and biochemist. He and Martin Rodbell shared the 1994 Nobel Prize in Physiology or Medicine "for their discovery of G-proteins and the role of these proteins in signal transduction in cells."

<span class="mw-page-title-main">Cyclophosphamide</span> Medication used as chemotherapy and to suppress the immune system

Cyclophosphamide (CP), also known as cytophosphane among other names, is a medication used as chemotherapy and to suppress the immune system. As chemotherapy it is used to treat lymphoma, multiple myeloma, leukemia, ovarian cancer, breast cancer, small cell lung cancer, neuroblastoma, and sarcoma. As an immune suppressor it is used in nephrotic syndrome, granulomatosis with polyangiitis, and following organ transplant, among other conditions. It is taken by mouth or injection into a vein.

<span class="mw-page-title-main">Chlormethine</span> Chemical compound

Chlormethine, also known as mechlorethamine, mustine, HN2, and embikhin (эмбихин), is a nitrogen mustard sold under the brand name Mustargen among others. It is the prototype of alkylating agents, a group of anticancer chemotherapeutic drugs. It works by binding to DNA, crosslinking two strands and preventing cell duplication. It binds to the N7 nitrogen on the DNA base guanine. As the chemical is a blister agent, its use is strongly restricted within the Chemical Weapons Convention where it is classified as a Schedule 1 substance.

<span class="mw-page-title-main">History of cancer chemotherapy</span>

The era of cancer chemotherapy began in the 1940s with the first use of nitrogen mustards and folic acid antagonist drugs. The targeted therapy revolution has arrived, but many of the principles and limitations of chemotherapy discovered by the early researchers still apply.

<span class="mw-page-title-main">Nitrogen mustard</span> Family of chemical compounds

Nitrogen mustards (NMs) are cytotoxic organic compounds with the bis(2-chloroethyl)amino ((ClC2H4)2NR) functional group. Although originally produced as chemical warfare agents, they were the first chemotherapeutic agents for treatment of cancer. Nitrogen mustards are nonspecific DNA alkylating agents.

Maxwell Myer Wintrobe was an Austrian-born American physician who was a 20th-century authority in the medical field of hematology and one of the pioneers of chemotherapy. His 1942 textbook on hematology, Clinical Hematology, was the first dedicated work in the field and he contributed to the diagnostic approach of anemia and copper metabolism, amongst many other achievements.

<span class="mw-page-title-main">Chlorambucil</span> Chemical compound

Chlorambucil, sold under the brand name Leukeran among others, is a chemotherapy medication used to treat chronic lymphocytic leukemia (CLL), Hodgkin lymphoma, and non-Hodgkin lymphoma. For CLL it is a preferred treatment. It is given by mouth.

<i>Goodman & Gilmans The Pharmacological Basis of Therapeutics</i>

Goodman & Gilman's The Pharmacological Basis of Therapeutics, commonly referred to as the Blue Bible or Goodman & Gilman, is a textbook of pharmacology originally authored by Louis S. Goodman and Alfred Gilman. First published in 1941, the book is in its 14th edition, and has the reputation of being the "bible of pharmacology". The readership of this book include physicians of all therapeutic and surgical specialties, clinical pharmacologists, clinical research professionals and pharmacists.

<span class="mw-page-title-main">Thiotepa</span> Chemical compound

Thiotepa (INN), sold under the brand name Tepadina among others, is an anti-cancer medication.

<span class="mw-page-title-main">Estramustine phosphate</span> Chemical compound

Estramustine phosphate (EMP), also known as estradiol normustine phosphate and sold under the brand names Emcyt and Estracyt, is a dual estrogen and chemotherapy medication which is used in the treatment of prostate cancer in men. It is taken multiple times a day by mouth or by injection into a vein.

<span class="mw-page-title-main">Ifosfamide</span> Chemotherapy medication

Ifosfamide (IFO), sold under the brand name Ifex among others, is a chemotherapy medication used to treat a number of types of cancer. This includes testicular cancer, soft tissue sarcoma, osteosarcoma, bladder cancer, small cell lung cancer, cervical cancer, and ovarian cancer. It is administered by injection into a vein.

<span class="mw-page-title-main">Thioxanthene</span> Chemical compound

Thioxanthene is a chemical compound in which the oxygen atom in xanthene is replaced with a sulfur atom. It is also related to phenothiazine. Several of its derivatives are used as typical antipsychotics in the treatment of schizophrenia and other psychoses.

<span class="mw-page-title-main">Alkylating antineoplastic agent</span> Pharmaceutical drugs

An alkylating antineoplastic agent is an alkylating agent used in cancer treatment that attaches an alkyl group (CnH2n+1) to DNA.

<span class="mw-page-title-main">Alfred Gilman Sr.</span> American pharmacologist (1908–1984)

Alfred Zack Gilman was an American pharmacologist best known for pioneering early chemotherapy techniques using nitrogen mustard with his colleague, Louis S. Goodman. The pair also published the classic textbook The Pharmacological Basis of Therapeutics in 1941, and Gilman served as an editor for its first six editions. Gilman served on the faculties of the Yale School of Medicine, the Columbia College of Physicians and Surgeons, and the Albert Einstein College of Medicine, where he founded the Department of Pharmacology. He was a member of U.S. National Academy of Sciences.

<span class="mw-page-title-main">Jane C. Wright</span> American cancer researcher

Jane Cooke Wright was a pioneering cancer researcher and surgeon noted for her contributions to chemotherapy. In particular, Wright is credited with developing the technique of using human tissue culture rather than laboratory mice to test the effects of potential drugs on cancer cells. She also pioneered the use of the drug methotrexate to treat breast cancer and skin cancer.

<span class="mw-page-title-main">Yale Cancer Center</span> Hospital in Connecticut, United States

Yale Cancer Center (YCC) was founded in 1974 as a result of an act of Congress in 1971, which declared the nation's "war on cancer". It is one of a network of 56 Comprehensive Cancer Centers designated by the National Cancer Institute (NCI). Currently directed by Dr. Eric Winer, the Cancer Center brings together the resources of the Yale School of Medicine (YSM), Yale New Haven Hospital (YNHH), and the Yale School of Public Health (YSPH).

<span class="mw-page-title-main">Intrinsic activity</span> Measure of relative response to a drug

Intrinsic activity (IA) and efficacy refer to the relative ability of a drug-receptor complex to produce a maximum functional response. This must be distinguished from the affinity, which is a measure of the ability of the drug to bind to its molecular target, and the EC50, which is a measure of the potency of the drug and which is proportional to both efficacy and affinity. This use of the word "efficacy" was introduced by Stephenson (1956) to describe the way in which agonists vary in the response they produce, even when they occupy the same number of receptors. High efficacy agonists can produce the maximal response of the receptor system while occupying a relatively low proportion of the receptors in that system. There is a distinction between efficacy and intrinsic activity.

<span class="mw-page-title-main">University of Utah School of Medicine</span> Medical school of the University of Utah

The University of Utah School of Medicine is located on the upper campus of the University of Utah in Salt Lake City, Utah. It was founded in 1905 and is currently the only MD-granting medical school in the state of Utah.

<span class="mw-page-title-main">Normustine</span> Nitrogen mustard used as a chemotherapy agent

Normustine, also known as bis(2-chloroethyl)carbamic acid, is a nitrogen mustard and alkylating antineoplastic agent. It is a metabolite of a number of antineoplastic agents that have been developed for the treatment of tumors, including estramustine phosphate, alestramustine, cytestrol acetate, and ICI-85966 (stilbostat), but only the former of which has actually been marketed.

References

  1. 1 2 3 4 Altman, Lawrence K. (28 November 2000). "Dr. Louis S. Goodman, 94, Chemotherapy Pioneer, Dies". New York Times. Retrieved 25 March 2015.
  2. Ritchie, Murdoch (1996). A Biographical Memoir of Albert Gilman (PDF). National Academies Press. Retrieved 26 March 2015.
  3. 1 2 Schiff, Judith Ann (May 2011). "Pioneers in chemotherapy". Yale Alumni Magazine . Retrieved 26 March 2015.
  4. 1 2 "Louis Goodman". National Academy of Sciences. Retrieved 26 March 2015.
  5. 1 2 "Dr. Louis S. Goodman dies, cancer pioneer, U. professor". Deseret News . 26 November 2000. Archived from the original on April 2, 2015. Retrieved 26 March 2015.